AbbVie (ABBV) Dividends payables (2013 - 2015)

AbbVie (ABBV) has reported Dividends payables for 3 consecutive years, with $924.0 million the latest figure, recorded in Q4 2015.

• On a quarterly basis, Dividends payables rose 16.81% year-over-year to $924.0 million in Q4 2015; TTM through Dec 2015 was $924.0 million, a 16.81% increase from a year earlier, with the FY2015 full-year figure at $924.0 million, up 16.81% from the prior year.
• Dividends payables was $924.0 million for Q4 2015 at AbbVie, up from $791.0 million in the prior quarter.
• Over five years, Dividends payables peaked at $924.0 million in Q4 2015 and troughed at $643.0 million in Q4 2013.
• A 3-year average of $786.0 million and a median of $791.0 million in 2014 frame the typical range for Dividends payables.
• Across the five-year window, Dividends payables advanced 23.02% in 2014 and advanced 16.81% in 2015, its largest moves.
• Over 3 years, Dividends payables stood at $643.0 million in 2013, then increased by 23.02% to $791.0 million in 2014, then increased by 16.81% to $924.0 million in 2015.
• The last three Dividends payables figures came in at $924.0 million (Q4 2015), $791.0 million (Q4 2014), and $643.0 million (Q4 2013), per Business Quant data.